Goldman Sachs Group Inc Amyris, Inc. Put Options Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 14, 2024	SELL	$1.09 - $1.82 $327,000 - $546,000	-300,000 Reduced 65.22%	160,000 $217,000
Q1 2023 May 11, 2023	SELL	$1.09 - $1.82 $327,000 - $546,000	-300,000 Reduced 65.22%	160,000 $217,000
Q4 2022 May 14, 2024	BUY	$1.52 - $3.39 $456,000 - $1.02 Million	300,000 Added 187.5%	460,000 $703,000
Q4 2022 Feb 13, 2023	BUY	$1.52 - $3.39 $456,000 - $1.02 Million	300,000 Added 187.5%	460,000 $703,000
Q3 2022 May 14, 2024	BUY	$1.7 - $4.05 $272,000 - $648,000	160,000 New	160,000 $467,000
Q3 2022 Nov 10, 2022	BUY	$1.7 - $4.05 $272,000 - $648,000	160,000 New	160,000 $467,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.